Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function
- PMID: 3704568
- DOI: 10.3109/00365598609024478
Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function
Abstract
Twenty consecutive female patients with urge incontinence and stable detrusor function on provocative rapid fill CO2-cystometry were treated as out-patients with a bladder training programme and with terodiline/placebo in a double-blind cross-over design. Frequency and incontinence episodes decreased significantly, while first sensation and cystometric bladder capacity increased. Both objectively and subjectively terodiline was significantly better than placebo with 50% (95% confidence limits 18-82) more patients improved on terodiline than on placebo. Thirty percent of the patients (95% confidence limits 12-54) relapsed after withdrawal of terodiline. At 3 months follow-up the remaining 70% were satisfied with the outcome of the training programme. Side effects were mild and reversible. Serum creatinine and alkaline phosphatase increased slightly on terodiline and the diastolic blood pressure was probably also increased by terodiline. In conclusion, female patients with idiopathic urge incontinence and stable detrusor function did respond to treatment as do female patients with urge incontinence and proven instability.
Similar articles
-
Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.Scand J Urol Nephrol Suppl. 1984;87:35-47. Scand J Urol Nephrol Suppl. 1984. PMID: 6443541 Clinical Trial.
-
Terodiline with bladder retraining for treating detrusor instability in elderly people.BMJ. 1991 Apr 27;302(6783):994-6. doi: 10.1136/bmj.302.6783.994. BMJ. 1991. PMID: 2039897 Free PMC article. Clinical Trial.
-
Terodiline in the treatment of women with urgency and motor urge incontinence. A clinical and urodynamic double-blind cross-over study.Br J Urol. 1986 Apr;58(2):129-33. doi: 10.1111/j.1464-410x.1986.tb09011.x. Br J Urol. 1986. PMID: 3516296 Clinical Trial.
-
Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence.Drugs. 1990 Nov;40(5):748-61. doi: 10.2165/00003495-199040050-00008. Drugs. 1990. PMID: 2292235 Review.
-
Functional daytime incontinence: pharmacological treatment.Scand J Urol Nephrol Suppl. 1992;141:108-14; discussion 115-6. Scand J Urol Nephrol Suppl. 1992. PMID: 1609246 Review.
Cited by
-
Tolerability and steady-state pharmacokinetics of terodiline and its main metabolites in elderly patients with urinary incontinence.Eur J Clin Pharmacol. 1989;36(5):487-93. doi: 10.1007/BF00558074. Eur J Clin Pharmacol. 1989. PMID: 2753067
-
Terodiline in the treatment of nocturnal enuresis in children.Int Urol Nephrol. 1992;24(5):509-13. doi: 10.1007/BF02550118. Int Urol Nephrol. 1992. PMID: 1459828
-
Adult urinary incontinence: Assessment, intervention, and the role of clinical health psychology in program development.J Clin Psychol Med Settings. 1994 Dec;1(4):339-61. doi: 10.1007/BF01991078. J Clin Psychol Med Settings. 1994. PMID: 24225861
-
Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD003193. doi: 10.1002/14651858.CD003193.pub4. Cochrane Database Syst Rev. 2012. PMID: 23235594 Free PMC article.
-
A calcium blocking and anticholinergic agent (terodiline) in the treatment of detrusor hyperreflexia: a placebo-controlled, cross-over trial.J Neurol Neurosurg Psychiatry. 1987 Oct;50(10):1331-6. doi: 10.1136/jnnp.50.10.1331. J Neurol Neurosurg Psychiatry. 1987. PMID: 3681312 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical